Aurobindo Pharma

AUROPHARMA

₹ 1,545.10

₹ 64.07

4.32%

Modeled data

Aurobindo Pharma
Market Sentiment

Timeline	Returns	Volume
Daily	4.32	30,87,783
Weekly	2.29%	40,88,043
Monthly	2.33%	1,82,26,412

Aurobindo Pharma
Performance

Timeline	Daily	Weekly	Monthly
AUROPHARMA	4.32	2.29%	2.33%
Index	-	-	-
Peer Avg.	-0.00%	2.70%	13.69%

*Avg of index constituents

Aurobindo Pharma
Fundamentals

Timeline	PE	PB	EV/EBIDTA	ROE	ROCE	Div. Yield
AUROPHARMA	20.87	1.94	6.14	10.16	10.67	2.07
Index	35.44	5.98	16.81	16.99	18.41	1.19
Peer Avg.	38.60	4.35	13.48	12.96	16.49	0.78

*Avg of index constituents

Aurobindo Pharma
Key Metrics

Metrics	Sales Growth	Profit Growth	ROE	ROCE
FY '21-22	-17.00%	-51.78%	10.16%	10.67%
FY '20-21	12.80%	77.18%	24.65%	26.68%
FY '19-20	13.57%	21.87%	17.00%	17.40%

Aurobindo Pharma
Shareholding Pattern

Promoters : 51.83%

FII : 20.83%

DII : 17.47%

Public : 9.86%

Others : 0.01%

Aurobindo Pharma
Profit & Loss

Metrics	Sales	Expenditure	EBITDA	PAT
FY '21-22	17,371.31	14,451.27	3,425.76	2,066.53
FY '20-21	20,299.15	15,572.53	5,211.97	4,251.05
FY '19-20	18,234.64	14,453.55	4,071.42	2,367.87

All values are in crores

Aurobindo Pharma
Peer Comparison

Metrics	Sales	Expenditure	EBITDA	PAT
AUROPHARMA	17,371.31	14,451.27	3,425.76	2,066.53
GLAND	4,400.71	2,890.31	1,734.33	1,211.91
BIOCON	4,961.10	4,183.65	1,215.60	532.30

All values are in crores

Aurobindo Pharma Share Price

Aurobindo Pharma Limited is an Indian pharmaceutical company. The main activity of the company is the production and distribution of active pharmaceutical ingredients, branded drugs, generic drugs and related services. Its product portfolio is divided into seven therapeutic/product areas which include CNS (CNS), Antiretrovirals (ARVs), Cardiovascular (CVS), SSP - Oral & Sterile, anti-infective, anti-diabetic and cephalosporins - orally. It develops various oncology and hormonal products. It develops topical and transdermal products for the therapeutic segment of dermatology. The company is also developing approximately three depot injections based on microsphere and nanosuspension technology platforms. The company distributes its products worldwide in about 150 countries. The company's subsidiaries include APL Healthcare Limited, Auronext Pharma Private Limited, Auro Peptides Limited, APL Pharma Thai Limited and others.

Aurobindo Pharma FAQs

How to Buy Aurobindo Pharma Share?

To purchase Aurobindo Pharma shares, you can open a Demat & Trading account through a broker or financial institution. Once your account is set up and funded, search for Aurobindo Pharma (ticker symbol: AUROPHARMA) on the trading platform provided by your broker and purchase the shares.

What's Aurobindo Pharma share price today?

The stock price of Aurobindo Pharma as of 13 Sep 2024 is ₹1,545.10

What is the Market Cap of Aurobindo Pharma?

Market capitalisation represents the total market value of a company's outstanding shares. As of 13 Sep 2024, Aurobindo Pharma (ticker symbol: AUROPHARMA) has a market capitalisation of approximately ₹2,54,97,11,85,706.35

What is the PE and PB ratio of Aurobindo Pharma?

Aurobindo Pharma Ltd's price-to-book ratio as of 13 Sep 2024 is 1.9422562, reflecting the market's valuation compared to its asset value. As of 13 Sep 2024, the trailing twelve months P/E (price-to-earnings) ratio is 20.871576, indicating the market values the company at around ₹20.87 for every ₹1 of earnings